Delivery Order SPE2DB20D2104-SPE2DB25FMXGX
- Not listed
- The Defense Logistics Agency awarded a $1,257.48 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded a $1,676.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert Rabies Vaccine with diluents, with a completion date of September 12, 2025. This non-set-aside contract represents a small-value transaction within the company's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.23 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.54 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This non-competitive delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price purchase under the company's existing contract vehicle. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of June 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,519.20 for Rabavert rabies vaccine with diluents on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.40 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract is firm fixed price with no set-aside designation and was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $26,596.25 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price contract, effective July 25, 2025, with ultimate completion by July 28, 2025, represents a small-value pharmaceutical procurement from the prime contractor's place of business in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents valued at $21,570.50 under a firm fixed price contract. This competitively awarded delivery order, with no set-aside designation, is scheduled for completion by July 30, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXGXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor relationship with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support program, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs and other federal health systems worldwide. The company's status as a major pharmaceutical distributor and established federal medical procurement vendor positions it as a critical supplier within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/8/25 |